En español
NIDA

Menu

Amphetamines

INVEST/CTN Fellow Targets Methamphetamine Use Among Filipino Adolescents

INVEST/Clinical Trials Network (CTN) Fellow Leonardo R. Estacio, Jr., Ph.D., M.P.H., spent his fellowship year focused on behavioral therapies to reduce methamphetamine abuse among adolescent Filipinos.

Report Warns of Worsening Drug Abuse in Myanmar Region

A new document, published by the United Nations Office on Drugs and Crime (UNODC), reports that the manufacture, trafficking, and consumption of amphetamine-type stimulant (ATS) drugs in Myanmar, one of the largest countries in Southeast Asia, is worsening.

New INVEST Fellow Investigates Cognitive Enhancer

New INVEST Drug Abuse Research Fellow Sujung Yoon, M.D., Ph.D., South Korea, will spend 12 months under the mentorship of Perry F. Renshaw, F.M.D., Ph.D., M.B.A., The Brain Institute, University of Utah, to focus on the application of multinuclear magnetic resonance spectroscopy markers of brain health in response to treatment.

Former DISCA Awardee and Colleagues Report Changes in Mexican Controls Reduced Methamphetamine Potency, Harm in United States

Former NIDA International Program Distinguished International Scientist Octavio Campollo, M.D., M.Sci., Ph.D., Mexico, and colleagues report in Drug and Alcohol Dependence that Mexico’s 2004 controls on ephedrine and pseudoephedrine changed the U.S. methamphetamine market. Restrictions on these precursor chemicals in Mexico resulted in widespread emergence of less potent methamphetamine and declines in prevalence and availability of the most potent type of the drug, which had dominated the U.S. market since the late 1980s. The authors found that U.S.

Subscribe to Amphetamines

Important Dates

NIDA International Program Fellowships

Application Deadlines:
Postdoctoral Fellowships:
April 1

Meetings

October 2 - October 6, 2014
Yokohama, Japan
October 18 - October 21, 2014
Berlin, Germany
November 15 - November 19, 2014
Washington, DC, USA